[1]
|
Gus, I. and Zielinsky, P. (1999) As cardiopatias no Brasil. In: Ferreira, C. and Póvoa, R., Eds., Cardiologiapara O ClínicoGeral, Atheneu, Rio de Janeiro, 131-143.
|
[2]
|
Thom, T., Haase, N., Rosamond, W., Howard, V.J. and American Heart Association. (2006) Stroke statistics heart disease and update. Circulation, 113, e85-e151.
|
[3]
|
Hatmi, Z.N., Tahvildari, S., GafarzadehMotlag, A. and SabouriKashani, A. (2007) Prevalence of coronary artery disease risk factors in Iran: Apopulation based survey. BMC Cardiovascular Disorders, 7, 32.
doi:10.1186/1471-2261-7-32
|
[4]
|
World Health Organization. (2002) The world health report 2002: Reducing risks, promoting healthy life. WHO, Geneva, 27 October 2002.
|
[5]
|
Naghavi, M. and Jafari, N. (2007) Death profile in Iran, 2005. Iranian Ministry of Health, Tehran.
|
[6]
|
Shimoda, M., Sugayama, S., Kim, C. and Ebaid, M. (1996) Orientacao Familiar preventiva: Aspectosgenéti cosdas doencascardiovasculares e perspectivasfuturas. Revista da Sociedade de Cardiologia do Estado de Sao Paulo, 6, 623-627.
|
[7]
|
Ockene, I.S. and Miller, N.H. (1997) Cigarette smoking, cardiovascular disease, and stroke. A statement for healthcare professionals from the American Heart Association. Circulation, 96, 3243-3247.
doi:10.1161/01.CIR.96.9.3243
|
[8]
|
Jee, S.H., Suh, I., Kim, I.S. and Appel, L.J. (1999) Smoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol: The Korea medical insurance corporation study. The Journal of the American Medical Association, 282, 2149-2155.
doi:10.1001/jama.282.22.2149
|
[9]
|
Steenland, K., Thun, M., Lally, C., et al. (1996) Environmental tobacco smoke and coronary heart disease in the American Cancer Society CPS-II cohort. Circulation, 94, 622-628. doi:10.1161/01.CIR.94.4.622
|
[10]
|
Kawachi, I., Colditz, G.A., Speizer, F.E., et al. (1997) A prospective study of passive smoking and coronary heart disease. Circulation, 95, 2374-2379.
doi:10.1161/01.CIR.95.10.2374
|
[11]
|
Law, M.R., Morris, J.K. and Wlad, N.J. (1997) Environ mental tobacco exposure and ischaemic heart disease: An evaluation of the evidence. British Medical Journal, 315, 973-980. doi:10.1136/bmj.315.7114.973
|
[12]
|
He, J., Vupputri, S., Allen, K., et al. (1999) Passive smoking and the risk of coronary heart diseasea meta-analisys of epidemiologic studies. The New England Journal of Medicine, 340, 920-926.
doi:10.1056/NEJM199903253401204
|
[13]
|
Fein, F. and Scheuer, J. (1990) Heart disease in diabetes mellitus: Theory and practice. In: Rifkin, H. and Port, D. Eds., Diabetes Mellitus, Elsever, New York, 812-823.
|
[14]
|
Aram, V. Chobanian, M.D. and Bakris, G.L. (2003) The 7th Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA, 289, 2560-2571.
|
[15]
|
Wilking, S.V.B., Belanger, A.J., Kannel, W.B., D’Agostinho, R.B. and Steel, K. (1988) Determinants of isolated systolic hypertension. The Journal of the American Medical Association, 260, 3451-3455.
doi:10.1001/jama.1988.03410230069030
|
[16]
|
Haghdoost, A.A. Sadeghirad, B. and Rezazadehkermani, M. (2008) Epidemiology and heterogeneity of hypertension in Iran: A systematic review. Archives of Iranian Medicine, 11, 444-452.
|
[17]
|
Gazino, J.M. (2005) Global burden of cardio vascular disease. In: Braunwald, E., Ed., Heart disease: A textbook of cardiovascular medicine, USA 7th Edition, WB Saunders Company, Philadelphia, 7.
|
[18]
|
Sarraf-Zadegan, N., Amboshtam, M. and Rafiei, M. (1999) Risk factors for coronary artery disease in Isfahan, Iran. European Journal of Public Health, 9, 20-26.
doi:10.1093/eurpub/9.1.20
|
[19]
|
Azizi, F., Rahmani, M., Emami, H., Mirmiran, P., Haji pour, R., Madjid, M., et al. (2002) Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). SOZ Preventive Medicine, 47, 408-426. doi:10.1007/s000380200008
|
[20]
|
Baguet, J.P., Barone-Rochette, G. and Mallion, J.M. (2006) European society of hypertension scientific news letter: Hypertension and coronary heart disease. Journal of Hypertension, 24, 2323-2325.
doi:10.1097/01.hjh.0000249719.05006.58
|
[21]
|
Akbarzadeh, F., Pourafkari, L., HashemiJazi, S.M., Hesami, L. and Habibi, V. (2010) Prevalence and severity of coronary of artery disease among hypertensive and nor motensive patients. ARYA Atherosclerosis Journal, 5, 186-190.
|
[22]
|
Gus, I., Fischmann, A. and Medina, C. (2002) Prevalence of risk factors for coronary artery disease in the brazilian state of riogrande do sul, Arquivos Brasileiros de Cardiologia, 78, 484-90.
doi:10.1590/S0066-782X2002000500005
|
[23]
|
Thelle, D.S., Shaper, A.G. and Whitehead, T.P. (1983) Blood lipids in middle-aged British men. British Heart Journal, 49, 5-13.
|
[24]
|
Sharifi, F., Mousavinasab, S.N., Soruri, R., Saeini, M. and Dinmohammadi, M. (2008) High prevalence of low high-density lipoprotein cholesterol concentrations and other dyslipidemic phenotypes in an Iranian population. Metabolic Syndrome and Related Disorders, 6, 187-95.
doi:10.1089/met.2008.0007
|
[25]
|
Ebrahimi, M., Kazemi-Bajestani, S.M., Ghayour-Mobar han, M., Moohebati, M., Paydar, R., Azimi-Nezhad, M., et al. (2009) Metabolic syndrome may not be a good predictor of coronary artery disease in the Iranian population: Population-specific definitions are required. The Scientific World Journal, 9, 86-96.
doi:10.1100/tsw.2009.17
|
[26]
|
Kazemi-Bajestani, S.M., Ghayour-Mobarhan, M., Ebrahimi, M., Moohebati, M., Esmaeili, H.A., Parizadeh, M.R., et al. (2007) Serum copper and zinc concentrations are lower in Iranian patients with angiographically de fined coronary artery disease than in subjects with a nor mal angiogram. Journal of Trace Elements in Medicine and Biology, 21, 22-28.
doi:10.1016/j.jtemb.2006.11.005
|
[27]
|
Ghayour-Mobarhan, M., Sahebkar, A., Parizadeh, S.M., Moohebati, M., Tavallaie, S., Rezakazemi-Bajestani, S.M., et al. (2008) Antibody titres to heat shock protein 27 are elevated in patients with acute coronary syndrome. International Journal of Experimental Pathology, 89, 209-215. doi:10.1111/j.1365-2613.2008.00586.x
|
[28]
|
Parizadeh, S.M., Moohebati, M., Ghafoori, F., Ghayour Mobarhan, M., Kazemi-Bajestani, S.M., Tavallaie, S., et al. (2009) Serum selenium and glutathione peroxidase concentrations in Iranian patients with angiography-de fined coronary artery disease. Angiology, 60, 186-191.
|
[29]
|
Janghorbani, M., Amini, M. and Tavassoli, A. (2006) Coronary heart disease in type 2 diabetes mellitus in Isfahan, Iran: Prevalence and risk factors. Acta Cardiologica, 61, 13-20. doi:10.2143/AC.61.1.2005135
|
[30]
|
Karimi, A., Marzban, M., Movahedi, N., Salehiomran, A., Sadeghian, S. and Goodarzynejad, H. (2009) Traditional cardiac risk factors profile in Iranian patients undergoing coronary artery bypass surgery. Acta Cardiologica, 64, 371-377.doi:10.2143/AC.64.3.2038024
|
[31]
|
Mohammad, K., Zali, M., Masjedi, M. and Majdzadeh, S. (1998) Cigarette smoking in Iran based on a national health survey. Medical Journal of the Islamic Republic of Iran, 1, 33-37.
|
[32]
|
Mohammad, K., Noorbala, A., Majdzadeh, S. and Karim loo, M. (2001) Trend of smoking prevalence in Iran from 1991 through 1999 based on two national health surveys. Hakim Research Journal, 4, 290-297.
|
[33]
|
Amani, R., Nourizadeh, M., et al. (2010) Nutritional related cardiovascular risk factors in patients with coronary artery disease in Iran: A case-control study. Nutrition Journal, 9, 70.
|